Success Stories: North America Immigration Law Group Got 2 Cases Approved (NIW + I-485 ) for a Bangladeshi Postdoctoral Associate in the Field of Biomedical Science

 

Client’s Testimonial:

“We are so grateful and blessed to work with you. We thank you so much for your all help throughout our application. We wish your continuous success.”


On August 7th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Florida

Approval Notice Date: August 7th, 2021

Processing Time: 11 months


Case Summary:

With millions of patients only in the United States suffering from different varieties of cancer, the proposed endeavor of our client to continue investigation into understanding molecular mechanisms associated with altered cancer metabolism and metabolic dysfunction in child malnutrition and to identify common unknown metabolic liabilities correlating with tumor microenvironmental components in order to illuminate cancer metabolic dark matter and discover novel anti-cancer metabolic targets, immediately attracted our attention. So, when he wanted to file for an NIW (National Interest Waiver) and I-485, we helped him by customizing his application to USCIS.

North America Immigration Law Group specializes in NIW petitions and we have an impressive 25,000+ approval record. This gives us an edge in deciding the most suitable legal strategies depending on the client’s background. This is why after thoroughly checking the background information, we went ahead to help the client in filing a customized petition. We were able to get him an NIW approval in a relatively short period of 11 months. We made this possible by including some of the following information in the application.

  • That his research has resulted in 15 peer-reviewed journal articles (9 of them first-authored), and one first-authored book chapter. Moreover, these papers have been published in the top journals of this field. He has published these papers in no fewer than 6 highly ranked peer-reviewed journals.
  • His research has also gone on to influence his peers. That is, his publications have been cited a total of 162 times according to Google Scholar.
  • He has completed at least 5 peer reviews to date. Since only the most highly esteemed researchers in the field are invited to evaluate the work of their peers, especially in authoritative journals like these, his position as a preeminent scholar is clear.
  • In recognition of the value and importance of his work, his research has been granted funding by the NIH, Bankhead-Coley Cancer Research Program, James and Esther King Biomedical Research Program, and Florida Breast Cancer Research Foundation. These institutions are dedicated to addressing substantial public health concerns within the U.S.
This is why one of the independent advisory opinions, that we suggested him to obtain said the following about him:

“The benefits of [the client's] research on the molecular mechanisms associated with altered cancer metabolism directly translates to positive patient outcomes for the millions of Americans afflicted with cancer.”

We thus wish him the best in all his future endeavors and we are assured that he will help progress the field in various novel ways. We are certain that his work would have a significant and tangible benefit to the national healthcare system, individual economic well-being, and national public health.